Cuéllar BA, Brussolo ME, García LJA, Hernández TH, Vázquez MO, Ocampo CJ, Garza RV

Language: Spanish
References: 6
Page: 489-492
PDF size: 121.71 Kb.

ABSTRACT

Basal cell carcinoma (BCC) is the most common malignancy worldwide and exceeds the prevalence of all other cancers combined. Citation rating is a useful tool to recognize valuable research and identify past and future trends in a specific field. We identified the most cited papers regarding treatment of BCC from the last decades to provide a bibliometric perspective of the progress in bcc research. The Web of Science (WOS) core collection (ISI-Thomson Reuters Web of Knowledge), a prominent scientific citation indexing platform, was used to search for bcc publications between 1975 to 2021. Search results were filtered to show the 100 most cited BCC articles. A total of 28 articles regarding treatment were extracted, including original research articles, editorials, correspondences, and review articles. Ninety-six percent were original articles (n = 27). The average citation count was 231.8. The country with most articles (corresponding author’s country) was USA (n = 14). The journal with most articles was The jama Dermatology (n = 8). The institution with most papers (corresponding author’s institution) was the Solano Dermatology Associates (n = 4). The treatment more frequently studied was photodynamic therapy (n = 11). The most frequent type of article was original randomized controlled trial (n = 12). The most cited article studied the inhibition of the Hedgehog pathway. Limitations to our review include utilizing data analysis from a single bibliometric source, time period bias, and including articles only in English. Bibliometric studies constitute an important tool to identify valuable research and the direction of scientific advancement. When available, imiquimod 5%, photodynamic therapy and Mohs surgery have become important treatment options in localized BCC. Moreover, Hedgehog pathway inhibitors are a breakthrough research discovery for advanced diseases.

REFERENCES

1. Cameron MC, Lee E, Hibler BP et al., Basal cell carcinoma: epidemiology,pathophysiology, clinical and histological subtypes, and diseaseassociations, J Am Acad Dermatol 2019; 80:303-17.

2. Adam D, The counting house, Nature 2002; 415:726-9.

3. Tao T, Zhao X, Lou J et al., The top cited clinical research articles onsepsis: a bibliometric analysis, Crit Care 2012; 16:R110.

4. Maymone MBC, Laughter M, Vashi NA et al., The most cited articlesand authors in dermatology: a bibliometric analysis of 1974-2019, J AmAcad Dermatol 2020; 83:201-5.

5. Van Loo E, Mosterd K, Krekels GA et al., Surgical excision versusMohs’ micrographic surgery for basal cell carcinoma of the face: arandomised clinical trial with 10 year follow-up, Eur J Cancer 2014;50:3011-20.

6. Tang JC, Hanke CW y Caro I., Vismodegib and the Hedgehog pathwayinhibitors: a historical perspective to current clinical application, J DrugsDermatol 2018; 17:506-8.